Browsing by Subject "Dementia"
Now showing items 1-12 of 12
-
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
(Brac University, 2023-02)Alzheimer's disease (AD) is a progressive neurological condition marked by memory or cognitive impairment, behavioral changes, visuospatial difficulties, decreased propensity to carry out day to day living tasks, and ... -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
(Brac University, 2023-10)Alzheimer’s disease is a neurodegenerative disease. Using FDA Adverse Event Reporting System database, a pharmacovigilance study for gender specific rhabdomyolysis risk in memantine users was conducted between January ... -
Immunotherapy for Alzheimer’s disease
(Brac University, 2022-02)Alzheimer's disease is one kind of a brain disorder which has the capability to destroy a person’s memory and thinking ability. To treat this disease various types of immunotherapies are required. This review is basically ... -
Mini-mental state examination in hospitalized post COVID-19 patient to identify the risk of AlzheiMer`s development
(Brac University, 2023-02)SARS Covid-19 has affected 6 million people in 2020 to 2022. The primary difficulty the patient faces respiratory difficulty. But the virus affects several peripheral systems as well. Central nervous system is one of the ... -
Mini-mental state examination in non-hospitalized post covid patients to identify cognitive decline
(Brac University, 2023-02)The WHO referred to the SARS-CoV-2 illness as COVID-19, an acronym for ""coronavirus disease 2019."" After an infection has cleared up, some individuals have experienced temporary or even long-lasting cognitive problems. ... -
A pharmacovigilance study of gender differences in rhabdomyolysis risk among donepezil users with alzheimer`s disease
(Brac University, 2023-10)Alzheimer’s disease is the most common disease for older patients marked by symptoms of dementia. This study was conducted for the pharmacovigilance investigation of donepezil related to adverse event rhabdomyolysis among ... -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
(Brac University, 2023-02)Alzheimer’s disease is an age-related neurodegenerative disease that effects the cognitive ability of a person. The cholinesterase inhibitor “donepezil” is used to treat Alzheimer's disease. Donepezil has shown the greatest ... -
A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
(Brac University, 2023-02)Alzheimer's Disease (AD) is a complex and common neurological disorder and dementia's leading cause. Memantine works to treat moderate to severe AD. This study focused on Food and Drug Administration Adverse Event Reporting ... -
A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
(Brac University, 2023-10)The study employed the Food and Drug Administration Adverse Event Reporting System (FAERS) database to study the impact of Rivastigmine, an acetylcholinesterase inhibitor (AChI), on patient mortality. The study determines ... -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
(Brac University, 2023-02)Galantamine is one of the common acetylcholinesterase inhibitors used to treat Alzheimer's disease, a neurodegenerative disorder. This study was conducted to determine the impact of galantamine on mortality rate and ... -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
(Brac University, 2023-02)The following study utilized the Food and Drug Administration Adverse Event Reporting System (FAERS) database to determine the AChI inhibitor, rivastigmine’s effect on patient mortality as well as its side effect of ... -
Status of cognitive decline in post covid-19 Bangladeshi patients
(Brac University, 2022-12)Coronavirus disease (COVID-19) patients had greater incidences of neurological and cognitive disorders. This research studied the link between neurological illness and Coronavirus. An investigation of the experiences of ...
